In accord with our results obtained via prazosin treatment, an earlier study showed that a quinazoline-like small molecule, doxazosin, activates EphA2 in a ligand-dependent manner and suppresses tumor cell metastasis in prostate cancer56. Here, EPHA2 is linked to urogenital neoplasm.